<unk> , sold under the brand name Aggrastat, is an antiplatelet medication. It belongs to a class of antiplatelets named glycoprotein IIb/IIIa inhibitors.<unk>  is a small molecule inhibitor of the protein-protein interaction between fibrinogen and the platelet integrin receptor GP IIb/IIIa and is the first drug candidate whose origins can be traced to a pharmacophore-based virtual screening lead.<unk>  has been available as a generic medication in the United States since April 2021.
Tirofiban
Tafamidis
Clopidogrel
Ticagrelor
Ticlopidine
Eptifibatide
Clofibride
Cetrorelix